nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00204	0.00204	CcSEcCtD
Betaxolol—Eye disorder—Cisplatin—germ cell cancer	0.00203	0.00203	CcSEcCtD
Betaxolol—Anaemia—Ifosfamide—germ cell cancer	0.00203	0.00203	CcSEcCtD
Betaxolol—Tinnitus—Cisplatin—germ cell cancer	0.00203	0.00203	CcSEcCtD
Betaxolol—Lymphadenopathy—Methotrexate—germ cell cancer	0.00202	0.00202	CcSEcCtD
Betaxolol—Cardiac disorder—Cisplatin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Betaxolol—Flushing—Cisplatin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Betaxolol—Discomfort—Dactinomycin—germ cell cancer	0.00202	0.00202	CcSEcCtD
Betaxolol—Anorexia—Bleomycin—germ cell cancer	0.002	0.002	CcSEcCtD
Betaxolol—Thrombophlebitis—Methotrexate—germ cell cancer	0.002	0.002	CcSEcCtD
Betaxolol—Diabetes mellitus—Methotrexate—germ cell cancer	0.00199	0.00199	CcSEcCtD
Betaxolol—Hypoaesthesia—Etoposide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Betaxolol—Malaise—Ifosfamide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Betaxolol—Vertigo—Ifosfamide—germ cell cancer	0.00198	0.00198	CcSEcCtD
Betaxolol—Immune system disorder—Cisplatin—germ cell cancer	0.00197	0.00197	CcSEcCtD
Betaxolol—Mediastinal disorder—Cisplatin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Betaxolol—Hypotension—Bleomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Betaxolol—Oedema—Dactinomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Betaxolol—Infection—Dactinomycin—germ cell cancer	0.00195	0.00195	CcSEcCtD
Betaxolol—Arrhythmia—Cisplatin—germ cell cancer	0.00195	0.00195	CcSEcCtD
Betaxolol—Palpitations—Ifosfamide—germ cell cancer	0.00194	0.00194	CcSEcCtD
Betaxolol—Alopecia—Cisplatin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Betaxolol—Cough—Ifosfamide—germ cell cancer	0.00192	0.00192	CcSEcCtD
Betaxolol—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00192	0.00192	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00191	0.00191	CcSEcCtD
Betaxolol—Erythema—Cisplatin—germ cell cancer	0.0019	0.0019	CcSEcCtD
Betaxolol—Malnutrition—Cisplatin—germ cell cancer	0.0019	0.0019	CcSEcCtD
Betaxolol—Paraesthesia—Bleomycin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Betaxolol—Dyspnoea—Bleomycin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Betaxolol—Myalgia—Ifosfamide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Betaxolol—Arthralgia—Ifosfamide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Betaxolol—Chest pain—Ifosfamide—germ cell cancer	0.00187	0.00187	CcSEcCtD
Betaxolol—Anorexia—Dactinomycin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Betaxolol—Eye disorder—Etoposide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Betaxolol—Flushing—Etoposide—germ cell cancer	0.00185	0.00185	CcSEcCtD
Betaxolol—Cardiac disorder—Etoposide—germ cell cancer	0.00185	0.00185	CcSEcCtD
Betaxolol—Discomfort—Ifosfamide—germ cell cancer	0.00185	0.00185	CcSEcCtD
Betaxolol—Hypersensitivity—Vinblastine—germ cell cancer	0.00183	0.00183	CcSEcCtD
Betaxolol—Decreased appetite—Bleomycin—germ cell cancer	0.00183	0.00183	CcSEcCtD
Betaxolol—Muscle spasms—Cisplatin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Betaxolol—Angiopathy—Etoposide—germ cell cancer	0.00181	0.00181	CcSEcCtD
Betaxolol—Confusional state—Ifosfamide—germ cell cancer	0.00181	0.00181	CcSEcCtD
Betaxolol—Immune system disorder—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Betaxolol—Mediastinal disorder—Etoposide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Betaxolol—Pain—Bleomycin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Betaxolol—Oedema—Ifosfamide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Betaxolol—Chills—Etoposide—germ cell cancer	0.00179	0.00179	CcSEcCtD
Betaxolol—Vision blurred—Cisplatin—germ cell cancer	0.00179	0.00179	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Betaxolol—Asthenia—Vinblastine—germ cell cancer	0.00178	0.00178	CcSEcCtD
Betaxolol—Infection—Ifosfamide—germ cell cancer	0.00178	0.00178	CcSEcCtD
Betaxolol—Tremor—Cisplatin—germ cell cancer	0.00178	0.00178	CcSEcCtD
Betaxolol—Alopecia—Etoposide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Betaxolol—Lethargy—Methotrexate—germ cell cancer	0.00176	0.00176	CcSEcCtD
Betaxolol—Nervous system disorder—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Betaxolol—Ill-defined disorder—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Betaxolol—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Betaxolol—Anaemia—Cisplatin—germ cell cancer	0.00175	0.00175	CcSEcCtD
Betaxolol—Skin disorder—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Betaxolol—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Betaxolol—Feeling abnormal—Bleomycin—germ cell cancer	0.00173	0.00173	CcSEcCtD
Betaxolol—Osteoarthritis—Methotrexate—germ cell cancer	0.00173	0.00173	CcSEcCtD
Betaxolol—Anorexia—Ifosfamide—germ cell cancer	0.00171	0.00171	CcSEcCtD
Betaxolol—Malaise—Cisplatin—germ cell cancer	0.00171	0.00171	CcSEcCtD
Betaxolol—Decreased appetite—Dactinomycin—germ cell cancer	0.0017	0.0017	CcSEcCtD
Betaxolol—Diarrhoea—Vinblastine—germ cell cancer	0.0017	0.0017	CcSEcCtD
Betaxolol—Dysgeusia—Etoposide—germ cell cancer	0.0017	0.0017	CcSEcCtD
Betaxolol—Fatigue—Dactinomycin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Betaxolol—Hypotension—Ifosfamide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Betaxolol—Pain—Dactinomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Betaxolol—Muscle spasms—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Betaxolol—Urticaria—Bleomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Betaxolol—Body temperature increased—Bleomycin—germ cell cancer	0.00166	0.00166	CcSEcCtD
Betaxolol—Dizziness—Vinblastine—germ cell cancer	0.00164	0.00164	CcSEcCtD
Betaxolol—Mood swings—Methotrexate—germ cell cancer	0.00164	0.00164	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00163	0.00163	CcSEcCtD
Betaxolol—Ataxia—Methotrexate—germ cell cancer	0.00162	0.00162	CcSEcCtD
Betaxolol—Myalgia—Cisplatin—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Feeling abnormal—Dactinomycin—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Paraesthesia—Ifosfamide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Ill-defined disorder—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Anxiety—Cisplatin—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Anaemia—Etoposide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.0016	0.0016	CcSEcCtD
Betaxolol—Dyspnoea—Ifosfamide—germ cell cancer	0.0016	0.0016	CcSEcCtD
Betaxolol—Discomfort—Cisplatin—germ cell cancer	0.00159	0.00159	CcSEcCtD
Betaxolol—Vomiting—Vinblastine—germ cell cancer	0.00158	0.00158	CcSEcCtD
Betaxolol—Malaise—Etoposide—germ cell cancer	0.00157	0.00157	CcSEcCtD
Betaxolol—Breast disorder—Methotrexate—germ cell cancer	0.00156	0.00156	CcSEcCtD
Betaxolol—Vertigo—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Betaxolol—Decreased appetite—Ifosfamide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Betaxolol—Headache—Vinblastine—germ cell cancer	0.00156	0.00156	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00156	0.00156	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Betaxolol—Body temperature increased—Dactinomycin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Betaxolol—Fatigue—Ifosfamide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Betaxolol—Oedema—Cisplatin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Betaxolol—Hypersensitivity—Bleomycin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Betaxolol—Infection—Cisplatin—germ cell cancer	0.00154	0.00154	CcSEcCtD
Betaxolol—Constipation—Ifosfamide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Betaxolol—Pain—Ifosfamide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Betaxolol—Loss of consciousness—Etoposide—germ cell cancer	0.00153	0.00153	CcSEcCtD
Betaxolol—Nervous system disorder—Cisplatin—germ cell cancer	0.00152	0.00152	CcSEcCtD
Betaxolol—Cough—Etoposide—germ cell cancer	0.00152	0.00152	CcSEcCtD
Betaxolol—Thrombocytopenia—Cisplatin—germ cell cancer	0.00151	0.00151	CcSEcCtD
Betaxolol—Tachycardia—Cisplatin—germ cell cancer	0.00151	0.00151	CcSEcCtD
Betaxolol—Asthenia—Bleomycin—germ cell cancer	0.00151	0.00151	CcSEcCtD
Betaxolol—Skin disorder—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Betaxolol—Hyperhidrosis—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Betaxolol—Asthma—Methotrexate—germ cell cancer	0.00149	0.00149	CcSEcCtD
Betaxolol—Pruritus—Bleomycin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Betaxolol—Feeling abnormal—Ifosfamide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Betaxolol—Chest pain—Etoposide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Betaxolol—Nausea—Vinblastine—germ cell cancer	0.00148	0.00148	CcSEcCtD
Betaxolol—Anorexia—Cisplatin—germ cell cancer	0.00147	0.00147	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00147	0.00147	CcSEcCtD
Betaxolol—Discomfort—Etoposide—germ cell cancer	0.00146	0.00146	CcSEcCtD
Betaxolol—Hypotension—Cisplatin—germ cell cancer	0.00145	0.00145	CcSEcCtD
Betaxolol—Hypersensitivity—Dactinomycin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Betaxolol—Confusional state—Etoposide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Betaxolol—Urticaria—Ifosfamide—germ cell cancer	0.00143	0.00143	CcSEcCtD
Betaxolol—Body temperature increased—Ifosfamide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00141	0.00141	CcSEcCtD
Betaxolol—Infection—Etoposide—germ cell cancer	0.00141	0.00141	CcSEcCtD
Betaxolol—Asthenia—Dactinomycin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Betaxolol—Dysuria—Methotrexate—germ cell cancer	0.0014	0.0014	CcSEcCtD
Betaxolol—Paraesthesia—Cisplatin—germ cell cancer	0.00139	0.00139	CcSEcCtD
Betaxolol—Thrombocytopenia—Etoposide—germ cell cancer	0.00139	0.00139	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00139	0.00139	CcSEcCtD
Betaxolol—Tachycardia—Etoposide—germ cell cancer	0.00138	0.00138	CcSEcCtD
Betaxolol—Dyspnoea—Cisplatin—germ cell cancer	0.00138	0.00138	CcSEcCtD
Betaxolol—Skin disorder—Etoposide—germ cell cancer	0.00138	0.00138	CcSEcCtD
Betaxolol—Erectile dysfunction—Methotrexate—germ cell cancer	0.00137	0.00137	CcSEcCtD
Betaxolol—Hyperhidrosis—Etoposide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Betaxolol—Anorexia—Etoposide—germ cell cancer	0.00135	0.00135	CcSEcCtD
Betaxolol—Decreased appetite—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Betaxolol—Diarrhoea—Dactinomycin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Betaxolol—Pneumonia—Methotrexate—germ cell cancer	0.00134	0.00134	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Betaxolol—Vomiting—Bleomycin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Betaxolol—Infestation NOS—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Betaxolol—Infestation—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Betaxolol—Depression—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Betaxolol—Hypotension—Etoposide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Betaxolol—Rash—Bleomycin—germ cell cancer	0.00132	0.00132	CcSEcCtD
Betaxolol—Pain—Cisplatin—germ cell cancer	0.00132	0.00132	CcSEcCtD
Betaxolol—Dermatitis—Bleomycin—germ cell cancer	0.00132	0.00132	CcSEcCtD
Betaxolol—Hypersensitivity—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Betaxolol—Stomatitis—Methotrexate—germ cell cancer	0.0013	0.0013	CcSEcCtD
Betaxolol—Conjunctivitis—Methotrexate—germ cell cancer	0.00129	0.00129	CcSEcCtD
Betaxolol—Asthenia—Ifosfamide—germ cell cancer	0.00129	0.00129	CcSEcCtD
Betaxolol—Sweating—Methotrexate—germ cell cancer	0.00128	0.00128	CcSEcCtD
Betaxolol—Feeling abnormal—Cisplatin—germ cell cancer	0.00127	0.00127	CcSEcCtD
Betaxolol—Paraesthesia—Etoposide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Betaxolol—Pruritus—Ifosfamide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Betaxolol—Dyspnoea—Etoposide—germ cell cancer	0.00126	0.00126	CcSEcCtD
Betaxolol—Epistaxis—Methotrexate—germ cell cancer	0.00126	0.00126	CcSEcCtD
Betaxolol—Nausea—Bleomycin—germ cell cancer	0.00125	0.00125	CcSEcCtD
Betaxolol—Vomiting—Dactinomycin—germ cell cancer	0.00125	0.00125	CcSEcCtD
Betaxolol—Agranulocytosis—Methotrexate—germ cell cancer	0.00124	0.00124	CcSEcCtD
Betaxolol—Rash—Dactinomycin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Betaxolol—Decreased appetite—Etoposide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Betaxolol—Diarrhoea—Ifosfamide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00122	0.00122	CcSEcCtD
Betaxolol—Body temperature increased—Cisplatin—germ cell cancer	0.00122	0.00122	CcSEcCtD
Betaxolol—Fatigue—Etoposide—germ cell cancer	0.00122	0.00122	CcSEcCtD
Betaxolol—Constipation—Etoposide—germ cell cancer	0.00121	0.00121	CcSEcCtD
Betaxolol—Pain—Etoposide—germ cell cancer	0.00121	0.00121	CcSEcCtD
Betaxolol—Dizziness—Ifosfamide—germ cell cancer	0.00119	0.00119	CcSEcCtD
Betaxolol—Pharyngitis—Methotrexate—germ cell cancer	0.00119	0.00119	CcSEcCtD
Betaxolol—Feeling abnormal—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Betaxolol—Nausea—Dactinomycin—germ cell cancer	0.00116	0.00116	CcSEcCtD
Betaxolol—Visual impairment—Methotrexate—germ cell cancer	0.00115	0.00115	CcSEcCtD
Betaxolol—Vomiting—Ifosfamide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Betaxolol—Hypersensitivity—Cisplatin—germ cell cancer	0.00114	0.00114	CcSEcCtD
Betaxolol—Rash—Ifosfamide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Betaxolol—Dermatitis—Ifosfamide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Betaxolol—Urticaria—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Betaxolol—Body temperature increased—Etoposide—germ cell cancer	0.00112	0.00112	CcSEcCtD
Betaxolol—Eye disorder—Methotrexate—germ cell cancer	0.00112	0.00112	CcSEcCtD
Betaxolol—Tinnitus—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Betaxolol—Asthenia—Cisplatin—germ cell cancer	0.00111	0.00111	CcSEcCtD
Betaxolol—Cardiac disorder—Methotrexate—germ cell cancer	0.00111	0.00111	CcSEcCtD
Betaxolol—Angiopathy—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Betaxolol—Immune system disorder—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Betaxolol—Mediastinal disorder—Methotrexate—germ cell cancer	0.00108	0.00108	CcSEcCtD
Betaxolol—Chills—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Betaxolol—Nausea—Ifosfamide—germ cell cancer	0.00107	0.00107	CcSEcCtD
Betaxolol—Diarrhoea—Cisplatin—germ cell cancer	0.00106	0.00106	CcSEcCtD
Betaxolol—Alopecia—Methotrexate—germ cell cancer	0.00106	0.00106	CcSEcCtD
Betaxolol—Mental disorder—Methotrexate—germ cell cancer	0.00105	0.00105	CcSEcCtD
Betaxolol—Hypersensitivity—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Betaxolol—Erythema—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Betaxolol—Malnutrition—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Betaxolol—Dysgeusia—Methotrexate—germ cell cancer	0.00102	0.00102	CcSEcCtD
Betaxolol—Asthenia—Etoposide—germ cell cancer	0.00102	0.00102	CcSEcCtD
Betaxolol—Pruritus—Etoposide—germ cell cancer	0.001	0.001	CcSEcCtD
Betaxolol—Vomiting—Cisplatin—germ cell cancer	0.000984	0.000984	CcSEcCtD
Betaxolol—Vision blurred—Methotrexate—germ cell cancer	0.00098	0.00098	CcSEcCtD
Betaxolol—Rash—Cisplatin—germ cell cancer	0.000975	0.000975	CcSEcCtD
Betaxolol—Dermatitis—Cisplatin—germ cell cancer	0.000975	0.000975	CcSEcCtD
Betaxolol—Diarrhoea—Etoposide—germ cell cancer	0.00097	0.00097	CcSEcCtD
Betaxolol—Ill-defined disorder—Methotrexate—germ cell cancer	0.000965	0.000965	CcSEcCtD
Betaxolol—Anaemia—Methotrexate—germ cell cancer	0.000961	0.000961	CcSEcCtD
Betaxolol—Malaise—Methotrexate—germ cell cancer	0.000938	0.000938	CcSEcCtD
Betaxolol—Dizziness—Etoposide—germ cell cancer	0.000937	0.000937	CcSEcCtD
Betaxolol—Vertigo—Methotrexate—germ cell cancer	0.000935	0.000935	CcSEcCtD
Betaxolol—Nausea—Cisplatin—germ cell cancer	0.000919	0.000919	CcSEcCtD
Betaxolol—Cough—Methotrexate—germ cell cancer	0.000908	0.000908	CcSEcCtD
Betaxolol—Vomiting—Etoposide—germ cell cancer	0.000901	0.000901	CcSEcCtD
Betaxolol—Rash—Etoposide—germ cell cancer	0.000894	0.000894	CcSEcCtD
Betaxolol—Dermatitis—Etoposide—germ cell cancer	0.000893	0.000893	CcSEcCtD
Betaxolol—Headache—Etoposide—germ cell cancer	0.000888	0.000888	CcSEcCtD
Betaxolol—Arthralgia—Methotrexate—germ cell cancer	0.000886	0.000886	CcSEcCtD
Betaxolol—Chest pain—Methotrexate—germ cell cancer	0.000886	0.000886	CcSEcCtD
Betaxolol—Myalgia—Methotrexate—germ cell cancer	0.000886	0.000886	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000879	0.000879	CcSEcCtD
Betaxolol—Discomfort—Methotrexate—germ cell cancer	0.000875	0.000875	CcSEcCtD
Betaxolol—Confusional state—Methotrexate—germ cell cancer	0.000856	0.000856	CcSEcCtD
Betaxolol—Infection—Methotrexate—germ cell cancer	0.000843	0.000843	CcSEcCtD
Betaxolol—Nausea—Etoposide—germ cell cancer	0.000842	0.000842	CcSEcCtD
Betaxolol—Nervous system disorder—Methotrexate—germ cell cancer	0.000833	0.000833	CcSEcCtD
Betaxolol—Thrombocytopenia—Methotrexate—germ cell cancer	0.000831	0.000831	CcSEcCtD
Betaxolol—Skin disorder—Methotrexate—germ cell cancer	0.000825	0.000825	CcSEcCtD
Betaxolol—Hyperhidrosis—Methotrexate—germ cell cancer	0.000821	0.000821	CcSEcCtD
Betaxolol—Anorexia—Methotrexate—germ cell cancer	0.000809	0.000809	CcSEcCtD
Betaxolol—Hypotension—Methotrexate—germ cell cancer	0.000793	0.000793	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000773	0.000773	CcSEcCtD
Betaxolol—Insomnia—Methotrexate—germ cell cancer	0.000768	0.000768	CcSEcCtD
Betaxolol—Paraesthesia—Methotrexate—germ cell cancer	0.000762	0.000762	CcSEcCtD
Betaxolol—Dyspnoea—Methotrexate—germ cell cancer	0.000757	0.000757	CcSEcCtD
Betaxolol—Dyspepsia—Methotrexate—germ cell cancer	0.000747	0.000747	CcSEcCtD
Betaxolol—Decreased appetite—Methotrexate—germ cell cancer	0.000738	0.000738	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000733	0.000733	CcSEcCtD
Betaxolol—Fatigue—Methotrexate—germ cell cancer	0.000732	0.000732	CcSEcCtD
Betaxolol—Pain—Methotrexate—germ cell cancer	0.000726	0.000726	CcSEcCtD
Betaxolol—Feeling abnormal—Methotrexate—germ cell cancer	0.0007	0.0007	CcSEcCtD
Betaxolol—Urticaria—Methotrexate—germ cell cancer	0.000674	0.000674	CcSEcCtD
Betaxolol—Body temperature increased—Methotrexate—germ cell cancer	0.000671	0.000671	CcSEcCtD
Betaxolol—Hypersensitivity—Methotrexate—germ cell cancer	0.000625	0.000625	CcSEcCtD
Betaxolol—Asthenia—Methotrexate—germ cell cancer	0.000609	0.000609	CcSEcCtD
Betaxolol—Pruritus—Methotrexate—germ cell cancer	0.000601	0.000601	CcSEcCtD
Betaxolol—Diarrhoea—Methotrexate—germ cell cancer	0.000581	0.000581	CcSEcCtD
Betaxolol—Dizziness—Methotrexate—germ cell cancer	0.000561	0.000561	CcSEcCtD
Betaxolol—Vomiting—Methotrexate—germ cell cancer	0.00054	0.00054	CcSEcCtD
Betaxolol—Rash—Methotrexate—germ cell cancer	0.000535	0.000535	CcSEcCtD
Betaxolol—Dermatitis—Methotrexate—germ cell cancer	0.000535	0.000535	CcSEcCtD
Betaxolol—Headache—Methotrexate—germ cell cancer	0.000532	0.000532	CcSEcCtD
Betaxolol—Nausea—Methotrexate—germ cell cancer	0.000504	0.000504	CcSEcCtD
